- Home
- AZTR vs XWEL Comparison
AZTR vs XWEL Comparison
Compare AZTR & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZTR
- XWEL
- Stock Information
- Founded
- AZTR 2014
- XWEL 2006
- Country
- AZTR United States
- XWEL United States
- Employees
- AZTR N/A
- XWEL N/A
- Industry
- AZTR Biotechnology: Pharmaceutical Preparations
- XWEL Other Consumer Services
- Sector
- AZTR Health Care
- XWEL Consumer Discretionary
- Exchange
- AZTR Nasdaq
- XWEL Nasdaq
- Market Cap
- AZTR 4.0M
- XWEL 4.7M
- IPO Year
- AZTR 2023
- XWEL N/A
- Fundamental
- Price
- AZTR $0.22
- XWEL $1.12
- Analyst Decision
- AZTR
- XWEL
- Analyst Count
- AZTR 0
- XWEL 0
- Target Price
- AZTR N/A
- XWEL N/A
- AVG Volume (30 Days)
- AZTR 798.9K
- XWEL 38.9K
- Earning Date
- AZTR 08-11-2025
- XWEL 08-13-2025
- Dividend Yield
- AZTR N/A
- XWEL N/A
- EPS Growth
- AZTR N/A
- XWEL N/A
- EPS
- AZTR N/A
- XWEL N/A
- Revenue
- AZTR $7,500.00
- XWEL $32,194,000.00
- Revenue This Year
- AZTR N/A
- XWEL N/A
- Revenue Next Year
- AZTR N/A
- XWEL N/A
- P/E Ratio
- AZTR N/A
- XWEL N/A
- Revenue Growth
- AZTR N/A
- XWEL 1.33
- 52 Week Low
- AZTR $0.21
- XWEL $0.70
- 52 Week High
- AZTR $1.25
- XWEL $2.42
- Technical
- Relative Strength Index (RSI)
- AZTR 37.04
- XWEL 56.23
- Support Level
- AZTR $0.22
- XWEL $0.90
- Resistance Level
- AZTR $0.24
- XWEL $1.42
- Average True Range (ATR)
- AZTR 0.01
- XWEL 0.09
- MACD
- AZTR -0.00
- XWEL 0.02
- Stochastic Oscillator
- AZTR 7.97
- XWEL 42.31
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.